Clinical trials
Phase 2 Prediabetic State trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 7 |
| Withdrawn | 6 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lund University | 2 |
| Novartis Pharmaceuticals | 2 |
| University Hospital, Basel, Switzerland | 2 |
| University of Guadalajara | 2 |
| Washington University School of Medicine | 2 |
| Aphaia Pharma US LLC | 1 |
| Beijing University of Chinese Medicine | 1 |
| Bo Feldt-Rasmussen | 1 |
| Brigham and Women's Hospital | 1 |
| Diana Jalal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 44 |
| Glucose Intolerance | 11 |
| Obesity | 10 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 7 |
| Insulin Resistance | 7 |
| Overweight | 6 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 1 | 3 |
| Inflammation | 3 |
Trials
Showing 76 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.